The distinct genetic pattern of ALS in Turkey and novel mutations

Neurobiology of Aging

Volumn 36, Issue 4, 2015, Pages 1764.e9-1764.e18

  Özoğuz, Aslihan ^a   Uyan, Özgün ^a   Birdal, Güneş ^a   Iskender, Ceren ^a   Kartal, Ece ^a   Lahut, Suna ^a   Ömür, Özgür ^a   Agim, Zeynep Sena ^a   Eken, Asli Gündoğdu ^a   Sen, Nesli Ece ^a   Kavak, Pinar ^a   Saygi, Ceren ^a   Sapp, Peter C ^b   Keagle, Pamela ^b   Parman, Yeşim ^c   Tan, Ersin ^d   Koç, Filiz ^e   Deymeer, Feza ^c   Oflazer, Piraye ^c   Hanağasi, Haşmet ^c   Gürvit, Hakan ^c   Bilgiç, Başar ^c   Durmuş, Hacer ^c   Ertaş, Mustafa ^f   Kotan, Dilcan ^g   Akalin, Mehmet Ali ^h   Güllüoğlu, Halil ⁱ   Zarifoğlu, Mehmet ^j   Aysal, Fikret ^k   Döşoğlu, Nilgün ^l   Bilguvar, Kaya ^m   Günel, Murat ^m   Keskin, Özlem ⁿ   Akgün, Tahsin ^o   Özçelik, Hilmi ^p   Landers, John E ^b   Brown, Robert H ^b   Başak, A Nazli ^a   more..

^a BOGAZICI UNIVERSITY   (Turkey)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c ISTANBUL UNIVERSITY   (Turkey)

^d HACETTEPE UNIVERSITY   (Turkey)

^e CUKUROVA UNIVERSITY   (Turkey)

^f LIV HOSPITAL   (Turkey)

^g SAKARYA UNIVERSITY   (Turkey)

^h ISTANBUL UNIVERSITY   (Turkey)

ⁱ Clinic of Cardiology   (Turkey)

^j ULUDAG UNIVERSITY   (Turkey)

^k BAKIRKOY DR SADI KONUK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^l HAYDARPASA NUMUNE EDUCATION AND RESEARCH HOSPITAL   (Turkey)

^m YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁿ KOÇ UNIVERSITY   (Turkey)

^o AMERICAN HOSPITAL   (Turkey)

^p MOUNT SINAI HOSPITAL   (Canada)

more..

Author keywords

ALS; C9orf72; FUS; SOD1; TDP 43; Turkey

Indexed keywords

COPPER ZINC SUPEROXIDE DISMUTASE; FUSED IN SARCOMA PROTEIN; TAR DNA BINDING PROTEIN; C9ORF72 PROTEIN, HUMAN; CELL CYCLE PROTEIN; DNA BINDING PROTEIN; FUS PROTEIN, HUMAN; GUANINE NUCLEOTIDE EXCHANGE FACTOR; NERVE PROTEIN; NUCLEAR PROTEIN; ONCOPROTEIN; OPTN PROTEIN, HUMAN; PARK7 PROTEIN, HUMAN; PLEKHG5 PROTEIN, HUMAN; PROTEIN; PROTEIN SERINE THREONINE KINASE; RNA BINDING PROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; SPG11 PROTEIN, HUMAN; SQSTM1 PROTEIN, HUMAN; SUPEROXIDE DISMUTASE; SYNE1 PROTEIN, HUMAN; TDP-43 PROTEIN, HUMAN; TRANSCRIPTION FACTOR IIIA; TRANSIENT RECEPTOR POTENTIAL CHANNEL M; TRPM7 PROTEIN, HUMAN; UBIQUITIN; UBQLN2 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; C9ORF72 GENE; CHILD; CONTROLLED STUDY; DJ1 GENE; EXOME; FAMILIAL AMYOTROPHIC LATERAL SCLEROSIS; FEMALE; FUS GENE; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC HETEROGENEITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; OPTN GENE; PLEKHG5 GENE; PRIORITY JOURNAL; SOD1 GENE; SPG11 GENE; SPORADIC AMYOTROPHIC LATERAL SCLEROSIS; SQSTM1 GENE; SYNE1 GENE; TARDBP GENE; TRPM7 GENE; TURKEY (REPUBLIC); UBQLN2 GENE; GENETIC ASSOCIATION; GENETICS; MIDDLE AGED; MUTATION; TURKEY; YOUNG ADULT;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADOLESCENT; ADULT; AGED; AMYOTROPHIC LATERAL SCLEROSIS; CELL CYCLE PROTEINS; DNA-BINDING PROTEINS; EXOME; FEMALE; GENETIC ASSOCIATION STUDIES; GUANINE NUCLEOTIDE EXCHANGE FACTORS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; NERVE TISSUE PROTEINS; NUCLEAR PROTEINS; ONCOGENE PROTEINS; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; RNA-BINDING PROTEIN FUS; SUPEROXIDE DISMUTASE; TRANSCRIPTION FACTOR TFIIIA; TRPM CATION CHANNELS; TURKEY; UBIQUITINS; YOUNG ADULT;

EID: 84925293541     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2014.12.032     Document Type: Article

References (39)

1. Al-Chalabi A., Jones A., Troakes C., King A., Al-Sarraj S., van den Berg L.H. The genetics and neuropathology of amyotrophic lateral sclerosis. Acta Neuropathol. 2012, 124:339-352.
2. Andersen P.M., Al-Chalabi A. Clinical genetics of amyotrophic lateral sclerosis: what do we really know?. Nat. Rev. Neurol. 2011, 7:603-615.
3. Andersen P.M., Nilsson P., Ala-Hurula V., Keranen M.L., Tarvainen I., Haltia T., Nilsson L., Binzer M., Forsgren L., Marklund S.L. Amyotrophic lateral sclerosis associated with homozygosity for an Asp90Ala mutation in CuZn-superoxide dismutase. Nat. Genet. 1995, 10:61-66.
4. Annesi G., Savettieri G., Pugliese P., D'Amelio M., Tarantino P., Ragonese P., La Bella V., Piccoli T., Civitelli D., Annesi F., Fierro B., Piccoli F., Arabia G., Caracciolo M., Ciro Candiano I.C., Quattrone A. DJ-1 mutations and parkinsonism-dementia-amyotrophic lateral sclerosis complex. Ann. Neurol. 2005, 58:803-807.
5. Battistini S., Giannini F., Greco G., Bibbo G., Ferrera L., Marini V., Causarano R., Casula M., Lando G., Patrosso M.C., Caponnetto C., Origone P., Marocchi A., Del Corona A., Siciliano G., Carrera P., Mascia V., Giagheddu M., Carcassi C., Orru S., Garre C., Penco S. SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study. J.Neurol. 2005, 252:782-788.
6. Belzil V.V., Daoud H., St-Onge J., Desjarlais A., Bouchard J.P., Dupre N., Lacomblez L., Salachas F., Pradat P.F., Meininger V., Camu W., Dion P.A., Rouleau G.A. Identification of novel FUS mutations in sporadic cases of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. 2011, 12:113-117.
7. Brooks B.R., Miller R.G., Swash M., Munsat T.L. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Other Motor Neuron Disord. 2000, 1:293-299.
8. Calvo A., Moglia C., Canosa A., Brunetti M., Barberis M., Traynor B.J., Carrara G., Valentini C., Restagno G., Chio A. Ade novo nonsense mutation of the FUS gene in an apparently familial amyotrophic lateral sclerosis case. Neurobiol. Aging 2014, 35:1513.e7-1513.e11.
9. Chio A., Restagno G., Brunetti M., Ossola I., Calvo A., Mora G., Sabatelli M., Monsurro M.R., Battistini S., Mandrioli J., Salvi F., Spataro R., Schymick J., Traynor B.J., La Bella V. Two Italian kindreds with familial amyotrophic lateral sclerosis due to FUS mutation. Neurobiol. Aging 2009, 30:1272-1275.
10. Daoud H., Zhou S., Noreau A., Sabbagh M., Belzil V., Dionne-Laporte A., Tranchant C., Dion P., Rouleau G.A. Exome sequencing reveals SPG11 mutations causing juvenile ALS. Neurobiol. Aging 2012, 33:839.e5-839.e9.
11. DeJesus-Hernandez M., Mackenzie I.R., Boeve B.F., Boxer A.L., Baker M., Rutherford N.J., Nicholson A.M., Finch N.A., Flynn H., Adamson J., Kouri N., Wojtas A., Sengdy P., Hsiung G.Y., Karydas A., Seeley W.W., Josephs K.A., Coppola G., Geschwind D.H., Wszolek Z.K., Feldman H., Knopman D.S., Petersen R.C., Miller B.L., Dickson D.W., Boylan K.B., Graff-Radford N.R., Rademakers R. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron 2011, 72:245-256.
12. Deng H.X., Chen W., Hong S.T., Boycott K.M., Gorrie G.H., Siddique N., Yang Y., Fecto F., Shi Y., Zhai H., Jiang H., Hirano M., Rampersaud E., Jansen G.H., Donkervoort S., Bigio E.H., Brooks B.R., Ajroud K., Sufit R.L., Haines J.L., Mugnaini E., Pericak-Vance M.A., Siddique T. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nature 2011, 477:211-215.
13. Deng H.X., Hentati A., Tainer J.A., Iqbal Z., Cayabyab A., Hung W.Y., Getzoff E.D., Hu P., Herzfeldt B., Roos R.P., Warner C., Deng G., Soriano E., Smyth C., Parge H.E., Ahmed A., Roses A.D., Hallewell R.A., Pericak-Vance M.A., Siddique T. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science 1993, 261:1047-1051.
14. Dillen L., Van Langenhove T., Engelborghs S., Vandenbulcke M., Sarafov S., Tournev I., Merlin C., Cras P., Vandenberghe R., De Deyn P.P., Jordanova A., Cruts M., Van Broeckhoven C., van der Zee J. Explorative genetic study of UBQLN2 and PFN1 in an extended Flanders-Belgian cohort of frontotemporal lobar degeneration patients. Neurobiol. Aging 2013, 34:1711.e1-1711.e5.
15. Fecto F., Yan J., Vemula S.P., Liu E., Yang Y., Chen W., Zheng J.G., Shi Y., Siddique N., Arrat H., Donkervoort S., Ajroud-Driss S., Sufit R.L., Heller S.L., Deng H.X., Siddique T. SQSTM1 mutations in familial and sporadic amyotrophic lateral sclerosis. Arch. Neurol. 2011, 68:1440-1446.
16. Ferraiuolo L., Kirby J., Grierson A.J., Sendtner M., Shaw P.J. Molecular pathways of motor neuron injury in amyotrophic lateral sclerosis. Nat. Rev. Neurol. 2011, 7:616-630.
17. Gamez J., Corbera-Bellalta M., Nogales G., Raguer N., Garcia-Arumi E., Badia-Canto M., Llado-Carbo E., Alvarez-Sabin J. Mutational analysis of the Cu/Zn superoxide dismutase gene in a Catalan ALS population: should all sporadic ALS cases also be screened for SOD1?. J.Neurol. Sci. 2006, 247:21-28.
18. Gellera C., Tiloca C., Del Bo R., Corrado L., Pensato V., Agostini J., Cereda C., Ratti A., Castellotti B., Corti S., Bagarotti A., Cagnin A., Milani P., Gabelli C., Riboldi G., Mazzini L., Soraru G., D'Alfonso S., Taroni F., Comi G.P., Ticozzi N., Silani V. Ubiquilin 2 mutations in Italian patients with amyotrophic lateral sclerosis and frontotemporal dementia. J.Neurol. Neurosurg. Psychiatry 2013, 84:183-187. SLAGEN Consortium.
19. Gitcho M.A., Baloh R.H., Chakraverty S., Mayo K., Norton J.B., Levitch D., Hatanpaa K.J., White C.L., Bigio E.H., Caselli R., Baker M., Al-Lozi M.T., Morris J.C., Pestronk A., Rademakers R., Goate A.M., Cairns N.J. TDP-43 A315T mutation in familial motor neuron disease. Ann. Neurol. 2008, 63:535-538.
20. Hadano S., Hand C.K., Osuga H., Yanagisawa Y., Otomo A., Devon R.S., Miyamoto N., Showguchi-Miyata J., Okada Y., Singaraja R., Figlewicz D.A., Kwiatkowski T., Hosler B.A., Sagie T., Skaug J., Nasir J., Brown R.H., Scherer S.W., Rouleau G.A., Hayden M.R., Ikeda J.E. Agene encoding a putative GTPase regulator is mutated in familial amyotrophic lateral sclerosis 2. Nat. Genet. 2001, 29:166-173.
21. Hanby M.F., Scott K.M., Scotton W., Wijesekera L., Mole T., Ellis C.E., Leigh P.N., Shaw C.E., Al-Chalabi A. The risk to relatives of patients with sporadic amyotrophic lateral sclerosis. Brain 2011, 134:3454-3457.
22. Hayward C., Brock D.J., Minns R.A., Swingler R.J. Homozygosity for Asn86Ser mutation in the CuZn-superoxide dismutase gene produces a severe clinical phenotype in a juvenile onset case of familial amyotrophic lateral sclerosis. J.Med. Genet. 1998, 35:174.
23. Hermosura M.C., Nayakanti H., Dorovkov M.V., Calderon F.R., Ryazanov A.G., Haymer D.S., Garruto R.M. ATRPM7 variant shows altered sensitivity to magnesium that may contribute to the pathogenesis of two Guamanian neurodegenerative disorders. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:11510-11515.
24. Lattante S., Rouleau G.A., Kabashi E. TARDBP and FUS mutations associated with amyotrophic lateral sclerosis: summary and update. Hum. Mutat. 2013, 34:812-826.
25. Majounie E., Renton A.E., Mok K., Dopper E.G., Waite A., Rollinson S., Chio A., Restagno G., Nicolaou N., Simon-Sanchez J., van Swieten J.C., Abramzon Y., Johnson J.O., Sendtner M., Pamphlett R., Orrell R.W., Mead S., Sidle K.C., Houlden H., Rohrer J.D., Morrison K.E., Pall H., Talbot K., Ansorge O., Hernandez D.G., Arepalli S., Sabatelli M., Mora G., Corbo M., Giannini F., Calvo A., Englund E., Borghero G., Floris G.L., Remes A.M., Laaksovirta H., McCluskey L., Trojanowski J.Q., Van Deerlin V.M., Schellenberg G.D., Nalls M.A., Drory V.E., Lu C.S., Yeh T.H., Ishiura H., Takahashi Y., Tsuji S., Le Ber I., Brice A., Drepper C., Williams N., Kirby J., Shaw P., Hardy J., Tienari P.J., Heutink P., Morris H.R., Pickering-Brown S., Traynor B.J. Frequency of the C9orf72 hexanucleotide repeat expansion in patients with amyotrophic lateral sclerosis and frontotemporal dementia: a cross-sectional study. Lancet Neurol. 2012, 11:323-330.
26. Maystadt I., Rezsohazy R., Barkats M., Duque S., Vannuffel P., Remacle S., Lambert B., Najimi M., Sokal E., Munnich A., Viollet L., Verellen-Dumoulin C. The nuclear factor kappaB-activator gene PLEKHG5 is mutated in a form of autosomal recessive lower motor neuron disease with childhood onset. Am. J. Hum. Genet. 2007, 81:67-76.
27. Millecamps S., Corcia P., Cazeneuve C., Boillee S., Seilhean D., Danel-Brunaud V., Vandenberghe N., Pradat P.F., Le Forestier N., Lacomblez L., Bruneteau G., Camu W., Brice A., Meininger V., LeGuern E., Salachas F. Mutations in UBQLN2 are rare in French amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:839.e1-839.e3.
28. Nakanishi T., Kishikawa M., Miyazaki A., Shimizu A., Ogawa Y., Sakoda S., Ohi T., Shoji H. Simple and defined method to detect the SOD-1 mutants from patients with familial amyotrophic lateral sclerosis by mass spectrometry. J.Neurosci. Methods 1998, 81:41-44.
29. Novembre J., Johnson T., Bryc K., Kutalik Z., Boyko A.R., Auton A., Indap A., King K.S., Bergmann S., Nelson M.R., Stephens M., Bustamante C.D. Genes mirror geography within Europe. Nature 2008, 456:98-101.
30. Orlacchio A., Babalini C., Borreca A., Patrono C., Massa R., Basaran S., Munhoz R.P., Rogaeva E.A., St George-Hyslop P.H., Bernardi G., Kawarai T. SPATACSIN mutations cause autosomal recessive juvenile amyotrophic lateral sclerosis. Brain 2010, 133:591-598.
31. Pasinelli P., Brown R.H. Molecular biology of amyotrophic lateral sclerosis: insights from genetics. Nat. Rev. Neurosci. 2006, 7:710-723.
32. Pfister T., Sekhon R., White M., Scott P., Munro S., Johnston M., Kalra S., Korngut L. Familial amyotrophic lateral sclerosis in Alberta, Canada. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013, 14:273-277.
33. Rabe M., Felbecker A., Waibel S., Steinbach P., Winter P., Muller U., Ludolph A.C. The epidemiology of CuZn-SOD mutations in Germany: a study of 217 families. J.Neurol. 2010, 257:1298-1302.
34. Renton A.E., Majounie E., Waite A., Simon-Sanchez J., Rollinson S., Gibbs J.R., Schymick J.C., Laaksovirta H., van Swieten J.C., Myllykangas L., Kalimo H., Paetau A., Abramzon Y., Remes A.M., Kaganovich A., Scholz S.W., Duckworth J., Ding J., Harmer D.W., Hernandez D.G., Johnson J.O., Mok K., Ryten M., Trabzuni D., Guerreiro R.J., Orrell R.W., Neal J., Murray A., Pearson J., Jansen I.E., Sondervan D., Seelaar H., Blake D., Young K., Halliwell N., Callister J.B., Toulson G., Richardson A., Gerhard A., Snowden J., Mann D., Neary D., Nalls M.A., Peuralinna T., Jansson L., Isoviita V.M., Kaivorinne A.L., Holtta-Vuori M., Ikonen E., Sulkava R., Benatar M., Wuu J., Chio A., Restagno G., Borghero G., Sabatelli M., Heckerman D., Rogaeva E., Zinman L., Rothstein J.D., Sendtner M., Drepper C., Eichler E.E., Alkan C., Abdullaev Z., Pack S.D., Dutra A., Pak E., Hardy J., Singleton A., Williams N.M., Heutink P., Pickering-Brown S., Morris H.R., Tienari P.J., Traynor B.J. Ahexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron 2011, 72:257-268.
35. Rutherford N.J., Zhang Y.J., Baker M., Gass J.M., Finch N.A., Xu Y.F., Stewart H., Kelley B.J., Kuntz K., Crook R.J., Sreedharan J., Vance C., Sorenson E., Lippa C., Bigio E.H., Geschwind D.H., Knopman D.S., Mitsumoto H., Petersen R.C., Cashman N.R., Hutton M., Shaw C.E., Boylan K.B., Boeve B., Graff-Radford N.R., Wszolek Z.K., Caselli R.J., Dickson D.W., Mackenzie I.R., Petrucelli L., Rademakers R. Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLoS Genet. 2008, 4:e1000193.
36. Ticozzi N., Tiloca C., Morelli C., Colombrita C., Poletti B., Doretti A., Maderna L., Messina S., Ratti A., Silani V. Genetics of familial amyotrophic lateral sclerosis. Arch. Ital. Biol. 2011, 149:65-82.
37. van Doormaal P.T., van Rheenen W., van Blitterswijk M., Schellevis R.D., Schelhaas H.J., de Visser M., van der Kooi A.J., Veldink J.H., van den Berg L.H. UBQLN2 in familial amyotrophic lateral sclerosis in The Netherlands. Neurobiol. Aging 2012, 33:2233.e7-2233.e8.
38. Vengoechea J., David M.P., Yaghi S.R., Carpenter L., Rudnicki S.A. Clinical variability and female penetrance in X-linked familial FTD/ALS caused by a P506S mutation in UBQLN2. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013, 14:615-619.
39. Williams K.L., Warraich S.T., Yang S., Solski J.A., Fernando R., Rouleau G.A., Nicholson G.A., Blair I.P. UBQLN2/ubiquilin 2 mutation and pathology in familial amyotrophic lateral sclerosis. Neurobiol. Aging 2012, 33:2527.e3-2527.e10.